Abstract

Coronavirus caused an epidemic in China in December 2019 at an animal market where live and dead animals were sold in Wuhan, China. In a short time, this epidemic spread to different continents.
This virus has been called the 2019 new coronavirus (2019-nCoV) by the World Health Organization. Unlike both MERS-CoV and SARS-CoV, Covid-19 is the seventh member of the coronavirus family that infects humans. It is characteristic for Covid-19 pneumonia that there are subpleural localized ground glass opacities and numerous irregular areas of consolidation in both lungs and especially in the lower lobes. In this case study, we aimed to present a Covid-19 positive in 58 years old man patient with cough, high fever, beginning breathlessness and chest pain on the left, accompanied by pneumothorax in the left hemithorax, after covid -19 diagnosis. Radiographic imaging of the patient revealed pneumothorax on the left and ground-glass opacities in the bilateral lower lobes. The patient underwent tube thoracostomy from the left hemithorax lateral.
It should be kept in mind that in patients with Covid-19 pneumonia, it may develop in pneumothoraces secondary to lung parenchymal damage. Mortality rates can be reduced in patients with early diagnosis and treatment.

Keywords: Covid-19; Pneumonia; Coronavirus; Pneumothorax; Computed Tomography; X-Ray

References

1. Stevens-Johnson Syndrome - EyeWiki (2018).
2. Ocular Manifestations of Stevens-Johnson Syndrome and Their Management (2016).
3. Chow LLW., et al. “Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study”. BMC Ophthalmology 65 (2017).
4. Gregory DG. “New grading system and treatment guidelines for the acute ocular manifestations of Stevens-Johnson syndrome”. Ophthalmology 8 (2016): 1653-1658.
5. Kohanim S., et al. “Stevens-Johnson syndrome/toxic epidermal necrolysis - a comprehensive review and guide to therapy. I. Systemic disease”. The Ocular Surface 1 (2016): 2-19.
6. Yip LW., et al. “High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits”. Eye 8 (2005): 846-853.
7. Aihara M., et al. “Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis”. Journal of Dermatological 8 (2015): 768-777.
8. Amniotic membrane transplantation can be useful in symblepharon lysis surgery (2010).

Citation

Citation: Juna Musa., et al. “Ophthalmic Manifestations and Type 4 of Hypersensitivity of Steven Johnson Syndrome-Toxic Epidermal Necrosis in Infants-Management and Literature Review".Acta Scientific Medical Sciences 4.10 (2020): 50-53.

Copyright

Copyright: © 2020 Juna Musa., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.